Angus A. Wilfong

Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial

Orrin Devinsky, Eric D. Marsh, Daniel J. Friedman et al. · The Lancet Neurology · 2015 · 890 citations

Cannabis Use, Psychotropic Medication, Neuropharmacology +5

Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial

Elizabeth A. Thiele, Eric D. Marsh, Jacqueline A. French et al. · The Lancet · 2018 · 868 citations

Placebo-controlled Phase 3, Neuropharmacology, Pharmacotherapy +4

Adjunctive perampanel for refractory partial-onset seizures

Jacqueline A. French, Gregory L. Krauss, Victor Biton et al. · Neurology · 2012 · 470 citations · Full text

MR-guided stereotactic laser ablation of epileptogenic foci in children

Daniel J. Curry, Ashok Gowda, Roger J. McNichols et al. · Epilepsy & Behavior · 2012 · 438 citations

Epileptogenic Foci, Laser Ablation, Image Guidance +2

Everolimus treatment of refractory epilepsy in tuberous sclerosis complex

Darcy A. Krueger, Angus A. Wilfong, Katherine Holland‐Bouley et al. · Annals of Neurology · 2013 · 381 citations · Full text